Atlas Trials

Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy

Clinical trial NCT06382103 · RECRUITING

Trial details

NCT number
NCT06382103
Sponsor
Shanghai Zhongshan Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2024-05-15
Primary completion
2025-05-20
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.